copper gluconate has been researched along with Parkinson Disease, Secondary in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Halbhübner, K; Herken, H; Loos, D | 1 |
| Diamond, B; Merlis, S; White, L; Yaryura-Tobias, JA | 1 |
| Aimard, G; Chazot, G; Devic, M; Eyssette, M; Fournis, Y | 1 |
1 trial(s) available for copper gluconate and Parkinson Disease, Secondary
| Article | Year |
|---|---|
The effect of calcium on behavior and drug-induced extrapyramidalism.
Topics: Adult; Calcium; Female; Gluconates; Humans; Male; Middle Aged; Motor Activity; Parkinson Disease; Parkinson Disease, Secondary; Phenothiazines; Placebos | 1969 |
2 other study(ies) available for copper gluconate and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Experimental neuropathy with Parkinson-like muscular rigidity. A suitable model for testing dopaminergic agonists and neuroleptic drugs.
Topics: 6-Aminonicotinamide; Animals; Antipsychotic Agents; Baclofen; Brain; Brain Chemistry; Bromocriptine; Central Nervous System Diseases; Disease Models, Animal; Dopamine; Drug Evaluation, Preclinical; Electromyography; Gluconates; Levodopa; Lisuride; Male; Motor Neurons; Muscle Contraction; Niacinamide; Parkinson Disease, Secondary; Rats; Reserpine; RNA; Spinal Cord; Sugar Phosphates | 1978 |
[Remarkable thymoanaleptic effect of lithium gluconate in recurrent melancholic states].
Topics: Antidepressive Agents; Depression; Gluconates; Humans; Lithium; Parkinson Disease, Secondary | 1971 |